Effectiveness and Tolerability of Eqwilate in Real-life Conditions

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)

NCT01410227 ·Status: COMPLETED ·Phase: PHASE3

A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

NCT07129343 ·Status: RECRUITING ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

NCT06998524 ·Status: RECRUITING ·Phase: PHASE3

Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age

NCT04953884 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

NCT03695978 ·Status: RECRUITING

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

NCT00816660 ·Status: COMPLETED ·Phase: PHASE1

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

NCT05582993 ·Status: RECRUITING ·Phase: PHASE3

A Study With OPTIVATE® in People With Von Willebrand Disease

NCT00387192 ·Status: TERMINATED ·Phase: PHASE3

Registry of Patients With Von WilLEbrand Disease Treated With Voncento®

NCT04657887 ·Status: COMPLETED

Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data

NCT04106895 ·Status: COMPLETED

A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)

NCT06433778 ·Status: COMPLETED

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

NCT02954575 ·Status: COMPLETED ·Phase: PHASE3

Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery

NCT02283268 ·Status: COMPLETED ·Phase: PHASE3

Observational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired Haemophilia

NCT01285089 ·Status: COMPLETED

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease

NCT06651255 ·Status: RECRUITING ·Phase: NA

A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With Veyvondi

NCT05265078 ·Status: COMPLETED

A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)

NCT03879135 ·Status: COMPLETED ·Phase: PHASE3

To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)

NCT04770935 ·Status: COMPLETED ·Phase: PHASE1

Von Willebrand Factor in Pregnancy (VIP) Study

NCT04146376 ·Status: RECRUITING

Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand Disease

NCT00941616 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Optivate in People With Von Willebrand Disease Undergoing Surgery

NCT00404300 ·Status: TERMINATED ·Phase: PHASE3

Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease

NCT00004667 ·Status: COMPLETED ·Phase: PHASE1

Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery

NCT01365546 ·Status: COMPLETED ·Phase: PHASE3

Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq

NCT03344003 ·Status: TERMINATED

Study of Biostate® in Children With Von Willebrand Disease

NCT01213446 ·Status: COMPLETED ·Phase: PHASE3